| Literature DB >> 21332503 |
M F Fernandez1, I Duran, N Olea, C Avivar, M Vierula, J Toppari, N E Skakkebaek, N Jørgensen.
Abstract
In North European countries, a significant difference in semen quality among young men has been shown. Men from the western countries, Denmark, Germany and Norway, have lower semen quality than men from the eastern countries Finland, Estonia and Lithuania. Similarly, men in the western countries have a higher risk of testicular cancer. According to the testicular dysgenesis syndrome (TDS) concept that suggests a link between risk of impaired semen quality and increased risk of testicular cancer, Spanish men would be expected to have a semen quality at a normal level because of their very low testis cancer risk. We therefore investigated 273 men from the Almeria region in the Southern Spain to test this hypothesis. The men delivered semen samples, underwent physical examinations, had a blood sample drawn and provided information on lifestyle and reproductive health parameters. The investigations took place from November 2001 to December 2002. Adjusting for effects of confounders, the median sperm concentration and total sperm count were 62 (95% confidence interval 47-82) million/mL and 206 (153-278) million, respectively. The median numbers of motile and morphologically normal spermatozoa assessed according to strict criteria were 59% (57-62%) and 9.4% (8.6-10.0%), respectively. The median total testosterone and calculated free androgen index were 28 nm (26-30) and 95 (88-103), respectively. Assuming that the investigated men, to a large extent, are representative of the population of young men the Southern Spain, the results show that these have normal semen quality and reproductive hormone levels as expected in a population with a low incidence of testicular cancer.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21332503 PMCID: PMC3380555 DOI: 10.1111/j.1365-2605.2010.01131.x
Source DB: PubMed Journal: Int J Androl ISSN: 0105-6263
Physical appearance and self-reported information of young men from the Almeria province in Spain
| Mean (SD) | Median (5–95) | |
|---|---|---|
| Height (cm) | 177.7 (6.4) | 178.0 (167.3–188.8) |
| Weight (kg) | 75.3 (10.5) | 75.0 (60.0–94.0) |
| BMI (kg/m2) | 23.8 (3.0) | 23.7 (19.6–29.4) |
| Size, left testis (mL) | 18.4 (4.7) | 20.0 (12.0–25.0) |
| Size, right testis (mL) | 18.6 (4.5) | 20.0 (12.0–25.0) |
| Mean of left and right size (mL) | 18.4 (4.6) | 20.0 (12.0–25.0) |
| Age (years) | 21.3 (2.1) | 20.9 (18.4–24.9) |
| Ejaculation abstinence (hour) | 75 (40) | 67 (35–156) |
| Frequency (%) | ||
| Have (had) | ||
| Cryptorchidism | 8.7 | |
| Cryptorchidism, treated | 3.6 | |
| STD diagnosed | 1.6 | |
| Varicocele diagnosed | 0.4 | |
| Inguinal hernia diagnosed | 1.2 | |
| Prolonged disease | 6.7 | |
| Diabetes or thyroid disease | 0.4 | |
| One or more of the above stated | 16.3 | |
| Good general health | 98.4 | |
| Taken medicine | 34.0 | |
| Smokers | 32.8 | |
| Cigarette smokers | 32.8 | |
| Marijuana/hashish smokers | 22.1 | |
| Exposed to tobacco in utero | 5.9 | |
SD, standard deviation.
(5–95): 5–95th percentile.
Size assessed by palpation. Two men had non-palpable right testicles, one due to previous orchidectomy because of cancer and one for unknown reasons.
Age calculated as difference between day of attendance in study and self-reported day of birth.
Ejaculation abstinence period calculated as difference between time of current ejaculation and self-reported time of previous ejaculation.
Not born with both testicles in scrotum (irrespective of spontaneous descend, treatment or still cryptorchid).
Hormonal, surgical or combination.
Diagnosed with epididymitis, chlamydia or gonorrhoea.
Question was ‘Have you ever had any long-lasting disease?’.
Question was ‘How will you describe your own health? Good, fair or poor’.
Taken any medication recent 3 months prior to participation in study. For 85%, it was either antibiotics or against allergy.
In utero exposed to maternal tobacco smoking.
Semen quality of young men from the Almeria province in Spain
| Observed – All men | Adjusted – All men | Adjusted – Subgroup | ||
|---|---|---|---|---|
| Mean (SD) | Median (5–95) | Median (95% CI) | Median (95% CI) | |
| Semen volume (mL) | 3.1 (1.5) | 3.0 (1.0–5.8) | 3.4 (3.0–3.7) | 3.4 (3.0–3.8) |
| Sperm concentration (million/mL) | 72 (70) | 51 (5–206) | 62 (47–82) | 75 (54–102) |
| Total sperm count (million) | 215 (240) | 149 (8–599) | 206 (153–278) | 246 (179–338) |
| Motile spermatozoa (%) | 59 (16) | 60 (28–85) | 59 (55–63) | 61 (58–64) |
| Morphologically normal forms (%) | 9.4 (5.5) | 8.3 (1.9–20.6) | 9.4 (8.7–10.2) | 9.6 (8.7–10.5) |
Observed: Results based on raw data.
SD, standard deviation.
(5–95): 5–95th percentile.
Adjusted median and 95% CI (confidence interval) calculated by linear regression analysis. Sperm concentration, total sperm counts and semen volume adjusted to a period of ejaculation abstinence of 96 h. Motility controlled for duration from ejaculation to assessment. Morphology adjusted for inter-observer variation. See text for further explanation.
All men: Results based on all men participating in the study.
Subgroup: Results entirely based on the 60.5% of the study population not taking any medication, men without any previous or current andrological diseases including known fertility problems. Information obtained from self-administered questionnaire.
Morphology results only available for 256 men.
Reproductive hormones of young men from the Almeria province in Spaina
| Observed – All men | Adjusted – All men | Adjusted – Subgroup | ||
|---|---|---|---|---|
| Mean (SD) | Median (5–95) | Median (95% CI) | Median (95% CI) | |
| FSH (U/L) | 3.1 (1.7) | 2.8 (1.1–6.5) | 2.5 (2.2–2.8) | 2.4 (2.1–2.8) |
| Inhibin-b (pg/mL) | 174 (67) | 164 (80–280) | 160 (144–177) | 174 (154–196) |
| LH (U/L) | 4.1 (1.8) | 3.8 (1.7–7.6) | 3.7 (3.4–4.1) | 3.8 (3.4–4.2) |
| Testosterone (n | 25 (8) | 24 (13–40) | 28 (26–30) | 28 (26–31) |
| SHBG (n | 30 (10) | 30 (14–48) | 29 (27–31) | 29 (26–31) |
| FAI | 90 (39) | 82 (42–166) | 95 (88–103) | 99 (90–100) |
Observed: Results based on raw data.
SD, standard deviation; FAI, free androgen index; FSH, follicle stimulating hormone; LH, luteinizing hormone; SHBG, sex hormone-binding globulin.
(5–95): 5–95th percentile.
Adjusted median and 95% CI (confidence interval) calculated by linear regression analysis, adjusted to blood sampling at 10:00 am.
All men: Results based on all men participating in the study.
Subgroup: Results entirely based on the 60.5% of the study population not taking any medication, men without any previous or current andrological diseases including known fertility problems. Information obtained from self-administered questionnaire.
Serum samples were only available for 250 of the 273 participants. Thus, hormonal results are based on these 250.
Calculated free androgen index.
Figure 1Sperm counts of young men from a south-eastern area of Spain shown together with previously published results from six North-European countries (Jørgensen ; Punab ; Paasch ). The bars show the adjusted median sperm concentration (million/mL) in the entire study populations (a) and in subgroups of men without any recent use of medicine or known andrological disease in their history (b), and total sperm count (mill) for the entire groups (c) or subgroups (d). Black, vertical lines show 95% confidence intervals of the estimated medians. A combined estimate for the German subgroup has not been published, and is therefore not included. The period of investigation of the studies is shown at the X-axis.